Preview: 2seventy bio's Earnings
Portfolio Pulse from Benzinga Insights
2seventy bio (NASDAQ:TSVT) is scheduled to release its quarterly earnings report on November 14, 2023. Analysts predict an EPS of $-0.97. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, 2seventy bio has surpassed EPS estimates, resulting in share price increases. However, the stock has declined 87.08% over the last 52 weeks, indicating long-term shareholder dissatisfaction.
November 13, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
2seventy bio is anticipated to report an EPS of $-0.97 for the upcoming quarter. Positive earnings results and guidance could potentially lead to a short-term increase in share price, as seen in past quarters.
Given 2seventy bio's history of surpassing EPS estimates and the subsequent positive impact on its stock price, there is a likelihood of a similar short-term positive reaction if the company beats the EPS estimate again and provides favorable guidance. However, the long-term downward trend in the stock price suggests underlying issues that may temper investor enthusiasm.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100